Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 84.72 USD -0.22% Market Closed
Market Cap: 11.5B USD
Have any thoughts about
Globus Medical Inc?
Write Note

Globus Medical Inc
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Globus Medical Inc
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Globus Medical Inc
NYSE:GMED
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Globus Medical Inc
Glance View

Market Cap
11.5B USD
Industry
Health Care

Globus Medical Inc. is a prominent player in the expanding spinal surgery market, leveraging innovation and patient-centric solutions to elevate the standards of care in orthopedic surgery. Founded in 2003, the company has quickly established itself as a leader by developing a comprehensive range of spinal implants and surgical instruments that emphasize minimally invasive techniques. This focus not only enhances patient recovery but also supports surgeons in their pursuit of optimal outcomes. With a robust pipeline of products and a commitment to research and development, Globus Medical aims to maintain its competitive edge by addressing the evolving needs of healthcare professionals and patients alike. For investors, Globus Medical represents a compelling opportunity, as its strong revenue growth and strategic initiatives indicate a promising future. The company has experienced consistent financial performance, underpinned by a growing market demand for spine-related procedures due to aging demographics and an increase in sports-related injuries. Moreover, Globus has pursued strategic acquisitions and collaborations, which have expanded its product offerings and geographical reach. As healthcare systems increasingly prioritize efficiency and patient outcomes, Globus Medical's innovative approach equips it to thrive in an industry ripe with potential, making it an attractive investment choice for those looking to capitalize on the evolving landscape of medical technology.

GMED Intrinsic Value
85.38 USD
Undervaluation 1%
Intrinsic Value
Price

See Also

Back to Top